1. Home
  2. GITS vs MBAI Comparison

GITS vs MBAI Comparison

Compare GITS & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Interactive Technologies Inc.

GITS

Global Interactive Technologies Inc.

HOLD

Current Price

$1.85

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

HOLD

Current Price

$8.30

Market Cap

8.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GITS
MBAI
Founded
2018
2004
Country
South Korea
Israel
Employees
5
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
8.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GITS
MBAI
Price
$1.85
$8.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.0K
76.7K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.95
52 Week High
$7.09
$10.21

Technical Indicators

Market Signals
Indicator
GITS
MBAI
Relative Strength Index (RSI) 44.90 89.50
Support Level $1.19 $1.19
Resistance Level $2.42 N/A
Average True Range (ATR) 0.28 0.38
MACD -0.04 0.87
Stochastic Oscillator 11.48 79.81

Price Performance

Historical Comparison
GITS
MBAI

About GITS Global Interactive Technologies Inc.

Global Interactive Technologies Inc is operating and developing Faning, a digital fan engagement platform focused on Korean entertainment and culture, including K-pop. Faning is designed to support online fan communities, user interaction, multilingual communication, and digital engagement experiences across mobile and web-based services. The platform evolved from the legacy Fantoo platform ecosystem. The Company's primary operational focus was the continued development, maintenance, and support of the Faning platform. The Company operates its business through its core Faning platform and strategy.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: